introduction cystic fibrosis cf disease caused inherited genetic defect pulmonary pancreatic abnormalities predominate clinical spectrum organ involvement common including liver severity liver disease does appear related severity exocrine pancreatic lung function discuss anaesthesia cf patients undergoing liver transplantation methods studied haemodynamic oxygenation modifications anaesthesia patients affected cf liver disease mild moderate pulmonary abnormalities patients received pancreatic enzyme prior transplantation diabetes mellitus patients treated antibiotic therapy waiting time ranging week months patients successfully transplanted general anaesthesia induced fentanyl thiopental pancuronium maintained isoflurane supplemented fentanyl o2air haemodynamic oxygenation evaluations main phases transplant intubation end procedure patients received toilet fiberoptic bronchoscopy results anaesthesia liver transplantation pao2 increased proportionally decreasing postoperative fev1 fvc improved preoperative time patients conclusion cystic fibrosis multisystem disease liver transplantation offered cf patients endstage liver disease mild moderate pulmonary function abnormalities patients alive enjoying good health improved respiratory function quality life children remarkable end stage insulin dependent broad spectrum broncho alveolar follow qs qt